Skip to main content

Advertisement

Log in

GSTM1 null polymorphisms and oral cancer risk: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Many studies have examined the association between the GSTM1 null gene polymorphism and oral cancer risk in various populations, but their results have been inconsistent. To assess this relationship more precisely, a meta-analysis was performed. The PubMed and Embase databases were searched for case–control studies published up to May 2013. Data were extracted and pooled odds ratio (OR) with 95 % confidence intervals (CI) were calculated. Ultimately, 39 studies, comprising of 4,704 oral cancer cases and 7,090 controls, were included. Overall, for null versus present, the pooled OR was 1.29 (95 % CI = 1.20–1.40), and the heterogeneity was found in all studies. In the stratified analysis by ethnicity, significant risks were found among Asians (OR = 1.39, 95 % CI = 1.27–1.53; P = 0.000 for heterogeneity), but not in Caucasians (OR = 0.99, 95 % CI = 0.83–1.18; P = 0.677 for heterogeneity). In conclusion, this meta-analysis demonstrates that the GSTM1 null gene polymorphism may be an increased risk of oral cancer in Asians but not in Caucasians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Zygogianni AG, Kyrgias G, Karakitsos P, Psyrri A, Kouvaris J, Kelekis N, et al. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol. 2011;3:2.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Reichart PA, Nguyen XH. Betel quid chewing, oral cancer, and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med. 2008;37:511–4.

    Article  CAS  PubMed  Google Scholar 

  3. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med. 1995;37:37–43.

    Article  CAS  PubMed  Google Scholar 

  4. Bolt HM, Thier R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab. 2006;7:613–28.

    Article  CAS  PubMed  Google Scholar 

  5. Wang Y, Spitz MR, Schabath MB, Ali-Osman F, Mata H, Wu X. Association between glutathione S-transferase P1 polymorphisms and lung cancer risk in Caucasians: a case–control study. Lung Cancer. 2003;40:25–32.

    Article  PubMed  Google Scholar 

  6. Seidegard J, Vorachek WR, Pero RW, et al. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA. 1988;85(19):7293–7.

    Article  CAS  PubMed  Google Scholar 

  7. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30(6):445–600.

    Article  CAS  PubMed  Google Scholar 

  8. Zhan P, Qian Q, Yu LK. Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis. 2013;5(1):40–7. doi:10.3978/j.issn.2072-1439.2013.01.02.

    PubMed Central  PubMed  Google Scholar 

  9. Zhan P, Qian Q, Wan B, Yan TD, Yu LK. Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis. Cancer Res: Transl; 2013.

    Google Scholar 

  10. Zhan P, Wang Q, Qian Q, Yu LK. Megestrol acetate in cancer patients with anorexia–cachexia syndrome: a meta-analysis. Transl Cancer Res. 2013;2(2):74–9. doi:10.3978/j.issn.2218-676X.2013.04.13.

    Google Scholar 

  11. Zhan P, Wang Q, Qian Q, Yu LK. Risk of venous thromboembolism with the erythropoiesis-stimulating agents (ESAs) for the treatment of cancer-associated anemia: a meta-analysis of randomized control trials. Chin Clin Oncol. 2013. doi:10.3978/j.issn.2304-3865.2013.01.02.

    Google Scholar 

  12. Zhan P, Qian Q, Yu LK. Prognostic significance of Vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis. Hepatobiliary Surg Nutr 2013 Jun 21. doi: 10.3978/j.issn.2304-3881.2013.06.06

  13. Zhan P, Qian Q, Yu LK. Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis. Hepatobiliary Surg Nutr 2013 Jun 28. doi: 10.3978/j.issn.2304-3881.2013.06.07

  14. Zhan P, Ji YN, Yu LK. VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis. Transl Androl Urol. 2013. doi:10.3978/j.issn.2223-4683.2013.07.01.

    Google Scholar 

  15. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.

    Article  Google Scholar 

  16. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  18. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8:15–7.

    Google Scholar 

  19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ. 1997;315:629–34.

    Article  CAS  PubMed  Google Scholar 

  20. Deakin M, Elder J, Hendrickse C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric, and colorectal cancers. Carcinogenesis. 1996;17(4):881–4.

    Article  CAS  PubMed  Google Scholar 

  21. Park JY, Muscat JE, Ren Q, et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev. 1997;6(10):791–7.

    CAS  PubMed  Google Scholar 

  22. Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1 environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(11):901–5.

    CAS  PubMed  Google Scholar 

  23. Matthias C, Bockmühl U, Jahnke V, et al. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics. 1998;8(2):91–100.

    Article  CAS  PubMed  Google Scholar 

  24. Jourenkova-Mironova N, Voho A, Bouchardy C, et al. Glutathione S-transferase GSTM1, GSTM3, GSTP1, and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer. 1999;81(1):44–8.

    Article  CAS  PubMed  Google Scholar 

  25. Sato M, Sato T, Izumo T, et al. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis. 1999;20(10):1927–31.

    Article  CAS  PubMed  Google Scholar 

  26. Katoh T, Kaneko S, Kohshi K, et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer. 1999;83(5):606–9.

    Article  CAS  PubMed  Google Scholar 

  27. Tanimoto K, Hayashi S, Yoshiga K, et al. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol. 1999;35(2):191–6.

    Article  CAS  PubMed  Google Scholar 

  28. Park LY, Muscat JE, Kaur T, et al. Comparison of GSTM polymorphisms and risk for oral cancer between African–Americans and Caucasians. Pharmacogenetics. 2000;10(2):123–31.

    Article  CAS  PubMed  Google Scholar 

  29. Nomura T, Noma H, Shibahara T, et al. Aldehyde dehydrogenase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers. Oral Oncol. 2000;36(1):42–6.

    Article  CAS  PubMed  Google Scholar 

  30. Sreelekha TT, Ramadas K, Pandey M, et al. Genetic polymorphism of CYP1A1, GSTM1, and GSTT1 genes in Indian oral cancer. Oral Oncol. 2001;37(7):593–8.

    Article  CAS  PubMed  Google Scholar 

  31. Kietthubthew S, Sriplung H, Au WW. Genetic and environmental interactions on oral cancer in Southern Thailand. Environ Mol Mutagen. 2001;37(2):111–6.

    Article  CAS  PubMed  Google Scholar 

  32. Buch SC, Notani PN, Bhisey RA. Polymorphism at GSTM1, GSTM3, and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis. 2002;23(5):803–7.

    Article  CAS  PubMed  Google Scholar 

  33. Hahn M, Hagedorn G, Kuhlisch E, et al. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncol. 2002;38(5):486–90.

    Article  CAS  PubMed  Google Scholar 

  34. Gronau S, Koenig-Greger D, Jerg M, et al. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis. 2003;9(2):62–7.

    Article  CAS  PubMed  Google Scholar 

  35. Sikdar N, Paul RR, Roy B. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Int J Cancer. 2004;109(1):95–101.

    Article  CAS  PubMed  Google Scholar 

  36. Xie H, Hou L, Shields PG, et al. Metabolic polymorphisms, smoking, and oral cancer in Puerto Rico. Oncol Res. 2004;14(6):315–20.

    PubMed  Google Scholar 

  37. Drummond SN, De Marco L, Noronha JC, et al. GSTM1 polymorphism and oral squamous cell carcinoma. Oral Oncol. 2004;40(1):52–5.

    Article  CAS  PubMed  Google Scholar 

  38. Majumder M, Sikdar N, Paul RR, et al. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3, and XRCC1 (codon 280). Cancer Epidemiol Biomarkers Prev. 2005;14(9):2106–12.

    Article  CAS  PubMed  Google Scholar 

  39. Liu CJ, Chang CS, Lui MT, et al. Association of GST genotypes with age of onset and lymph node metastasis in oral squamous cell carcinoma. J Oral Pathol Med. 2005;34(8):473–7.

    Article  PubMed  Google Scholar 

  40. Huang P, An Y, Wu C, Meng X. GSTT1, GSTM1 polymorphisms, and oral and maxillofacial cancer. J Pract Oncol (Chin). 2006;21(1):39–42.

    CAS  Google Scholar 

  41. Sugimura T, Kumimoto H, Tohnai I, et al. Gene–environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med. 2006;35(1):11–8.

    Article  CAS  PubMed  Google Scholar 

  42. Gattas GJ, de Carvalho MB, Siraque MS, et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck. 2006;28(9):819–26.

    Article  PubMed  Google Scholar 

  43. Sharma A, Mishra A, Das BC, et al. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer. Neoplasma. 2006;53(4):309–15.

    CAS  PubMed  Google Scholar 

  44. Anantharaman D, Chaubal PM, Kannan S, et al. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1, and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis. 2007;28(7):1455–62.

    Article  CAS  PubMed  Google Scholar 

  45. Cha IH, Park JY, Chung WY, et al. Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J. 2007;48(2):233–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Varela-Lema L, Ruano-Ravina A, Juiz Crespo MA, et al. CYP1A1, mEH, and GSTM1 polymorphisms and risk of oral and pharyngeal cancer: a Spanish case–control study. J Oncol 2008:741310.

  47. Hatagima A, Costa EC, Marques CF, Koifman RJ, Boffetta P, Koifman S. Glutathione S-transferase polymorphisms and oral cancer: a case–control study in Rio de Janeiro. Brazil Oral Oncol. 2008;44(2):200–7.

    Article  CAS  Google Scholar 

  48. Bathi RJ, Rao R, Mutalik S. GST null genotype and antioxidants: risk indicators for oral pre-cancer and cancer. Indian J Dent Res. 2009;20(3):298–303.

    Article  PubMed  Google Scholar 

  49. Amtha R, Ching CS, Zain R. GSTM1, GSTT1, and CYP1A1 polymorphisms and risk of oral cancer: a case–control study in Jakarta, Indonesia. Asian Pac J Cancer Prev. 2009;10(1):21–6.

    PubMed  Google Scholar 

  50. Chen MK, Tsai HT, Chung TT, et al. Glutathione S-transferase P1 and alpha gene variants: role in susceptibility and tumor size development of oral cancer. Head Neck. 2010;32(8):1079–87.

    Article  PubMed  Google Scholar 

  51. Sharma R, Ahuja M, Panda NK, et al. Combined effect of smoking and polymorphisms in tobacco carcinogen-metabolizing enzymes CYP1A1 and GSTM1 on the head and neck cancer risk in north Indians. DNA Cell Biol. 2010;29(8):441–8.

    Article  CAS  PubMed  Google Scholar 

  52. Cordero K, Espinoza I, Caceres D, Roco A, Miranda C, Squicciarini V, et al. Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals. Oncol Lett. 2010;1(3):549–53.

    CAS  PubMed Central  PubMed  Google Scholar 

  53. Lourenço GJ, Silva EF, Rinck-Junior JA, Chone CT, Lima CS. CYP1A1, GSTM1, and GSTT1 polymorphisms, tobacco and alcohol status, and risk of head and neck squamous cell carcinoma. Tumor Biol. 2011;32(6):1209–15.

    Article  Google Scholar 

  54. Masood N, Kayani MA, Malik FA, Mahjabeen I, Baig RM, Faryal R. Genetic variation in carcinogen metabolizing genes associated with oral cancer in Pakistani population. Asian Pac J Cancer Prev. 2011;12(2):491–5.

    PubMed  Google Scholar 

  55. Shukla D, Dinesh Kale A, Hallikerimath S, Vivekanandhan S, Venkatakanthaiah Y. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156(3):253–9.

    Article  CAS  PubMed  Google Scholar 

  56. Yadav DS, Devi TR, Ihsan R, Mishra AK, Kaushal M, Chauhan PS, et al. Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population. Genet Test Mol Biomarkers. 2010;14(5):715–23.

    Article  CAS  PubMed  Google Scholar 

  57. Mondal R, Ghosh SK, Choudhury JH, Seram A, Sinha K, Hussain M, et al. Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India. PLoS One. 2013;8(3):e57771.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Singh R, Haridas N, Shah F, Patel J, Shukla S, Patel P. Gene polymorphisms, tobacco exposure, and oral cancer susceptibility: a study from Gujarat. Oral Dis: West India; 2013. doi:10.1111/odi.12079.

    Google Scholar 

  59. Hirschhorn JN, Lohmueller K, Byrne E. A comprehensive review of genetic association studies. Genet Med. 2002;4:45–61.

    Article  CAS  PubMed  Google Scholar 

  60. Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, et al. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis. Am J Epidemiol. 2011;15;173(8):847–57.

    Article  Google Scholar 

  61. Zhou C, Zhou Y, Li J, Zhang Y, Jiang L, Zeng X, et al. Th ARG 194TRP polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis. Tohoku J Exp Med. 2009;219:43–51.

    Article  CAS  PubMed  Google Scholar 

  62. Niu Y, Hu Y, Wu M, Jiang F, Shen M, Tang C, et al. CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis. Mol Biol Rep. 2012;39:607–12.

    Article  CAS  PubMed  Google Scholar 

  63. Zhuo XL, Li Q, Zhou Y, Cai L, Xiang ZL, Yuan W, et al. Study on TP53 codon 72 poly morphisms wit h oral carcinoma susceptibility. Arch Med Res. 2009;40:625–34.

    Article  CAS  PubMed  Google Scholar 

  64. Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J Exp Clin Cancer Res. 2011;20:30–99.

    Google Scholar 

  65. Zhan P, Wang Q, Wei SZ, Wang J, Qian Q, Yu LK, et al. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case–control studies. J Thorac Oncol. 2010;5(9):1337–45.

    Article  PubMed  Google Scholar 

  66. Zhan P, Wang J, Zhang Y, Qiu LX, Zhao SF, Qian Q, et al. CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians. Lung Cancer. 2010;69(1):19–25.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to En-Yi Tang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, SF., Yang, XD., Lu, MX. et al. GSTM1 null polymorphisms and oral cancer risk: a meta-analysis. Tumor Biol. 35, 287–293 (2014). https://doi.org/10.1007/s13277-013-1037-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1037-z

Keywords

Navigation